- Home
- IMNM vs SXC Comparison
IMNM vs SXC Comparison
Compare IMNM & SXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- SXC
- Stock Information
- Founded
- IMNM 2006
- SXC 1960
- Country
- IMNM United States
- SXC United States
- Employees
- IMNM N/A
- SXC N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- SXC Steel/Iron Ore
- Sector
- IMNM Health Care
- SXC Industrials
- Exchange
- IMNM Nasdaq
- SXC Nasdaq
- Market Cap
- IMNM 770.1M
- SXC 710.2M
- IPO Year
- IMNM 2020
- SXC N/A
- Fundamental
- Price
- IMNM $7.46
- SXC $8.54
- Analyst Decision
- IMNM Strong Buy
- SXC Strong Buy
- Analyst Count
- IMNM 5
- SXC 1
- Target Price
- IMNM $26.40
- SXC $13.00
- AVG Volume (30 Days)
- IMNM 1.1M
- SXC 791.0K
- Earning Date
- IMNM 05-16-2025
- SXC 04-30-2025
- Dividend Yield
- IMNM N/A
- SXC 5.63%
- EPS Growth
- IMNM N/A
- SXC 51.30
- EPS
- IMNM N/A
- SXC 1.09
- Revenue
- IMNM $9,041,000.00
- SXC $1,883,000,000.00
- Revenue This Year
- IMNM N/A
- SXC N/A
- Revenue Next Year
- IMNM $1,259.12
- SXC $3.70
- P/E Ratio
- IMNM N/A
- SXC $7.83
- Revenue Growth
- IMNM N/A
- SXC N/A
- 52 Week Low
- IMNM $5.15
- SXC $7.47
- 52 Week High
- IMNM $19.07
- SXC $12.82
- Technical
- Relative Strength Index (RSI)
- IMNM 43.56
- SXC 36.49
- Support Level
- IMNM $7.15
- SXC $8.90
- Resistance Level
- IMNM $9.16
- SXC $9.28
- Average True Range (ATR)
- IMNM 0.51
- SXC 0.27
- MACD
- IMNM -0.08
- SXC -0.09
- Stochastic Oscillator
- IMNM 15.42
- SXC 4.10
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About SXC SunCoke Energy Inc.
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is primarily used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through three segments: Domestic Coke, Brazil Coke, and Logistics. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.